Amphastar Pharmaceuticals, Inc.
$1.32B- Market cap
- $986.88M
- Debt
- +$619.71M
- Cash
- −$282.81M
Capital structure 61% equity / 39% debt · EV / Revenue 1.84x · EV / EBITDA 6.20x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
AMPH · current priceP/E 11.43x
$23.20Latest market snapshot
Implied fair value · at SWX's multiple
$83.94261.8% above market
2.03 AMPH EPS (TTM)×41.35x SWX P/E=$83.94
Market $23.20Implied $83.94
SWX · current priceP/E 41.35x
$88.08Latest market snapshot
Implied fair value · at AMPH's multiple
$24.3472.4% below market
2.13 SWX EPS (TTM)×11.43x AMPH P/E=$24.34
Market $88.08Implied $24.34